Heartland Rehabilitation And Care Center Medicare and Medicaid Location: 19701 Interstate 30, Benton, Arkansas 72015 Ratings: Phone: (501) 778-8200 |
Alcoa Pines Health And Rehabilitation Medicare and Medicaid Location: 3300 Alcoa Road, Benton, Arkansas 72015 Ratings: Phone: (501) 315-1700 |
Amberwood Health And Rehabilitation Medicare and Medicaid Location: 6420 Alcoa Road, Benton, Arkansas 72015 Ratings: Phone: (501) 778-5401 |
Arkansas Health Center Medicaid Location: 6701 Hwy 67, Benton, Arkansas 72015 Ratings: Phone: (501) 860-0500 |
News Archive
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, and Jiangsu Hengrui Medicine Co., Ltd., a leading Chinese pharmaceutical company, today announced that Shanghai ChemPartner, a wholly owned subsidiary of ShangPharma, and Hengrui have entered into a strategic partnership for the development of novel therapeutic monoclonal antibodies.
The American College of Cardiology is developing a program with support from founding sponsor AstraZeneca to provide personalized services to heart disease patients and help avoid a quick return to the hospital.
Researchers from the Alberta Glycomics Centre at the University of Calgary and the University of Alberta, in collaboration with researchers at the National Research Council of Canada in Ottawa, have revealed the first molecular views showing how highly specific antibodies derived from llamas may provide a new method for controlling deadly infections from the opportunistic bacterial pathogen Clostridium difficile (C. difficile).
ARIAD Pharmaceuticals, Inc. today announced the commercial availability of Iclusig (ponatinib) for adult patients with refractory chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia in the United States. ARIAD has begun shipping Iclusig to Biologics, Inc., its exclusive specialty pharmacy, which is now filling prescriptions from physicians and distributing the cancer medicine to patients.
Akorn, Inc., a niche generic pharmaceutical company, today reported financial results for the first quarter ended March 31, 2014.
› Verified 7 days ago